CA967564A - Amino purine derivatives - Google Patents

Amino purine derivatives

Info

Publication number
CA967564A
CA967564A CA098,272A CA98272A CA967564A CA 967564 A CA967564 A CA 967564A CA 98272 A CA98272 A CA 98272A CA 967564 A CA967564 A CA 967564A
Authority
CA
Canada
Prior art keywords
purine derivatives
amino purine
amino
derivatives
purine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA098,272A
Other languages
English (en)
Other versions
CA98272S (en
Inventor
Robert A. Strelitz
Gertrude B. Elion
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Priority to CA210,441A priority Critical patent/CA973875A/en
Application granted granted Critical
Publication of CA967564A publication Critical patent/CA967564A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
CA098,272A 1969-11-17 1970-11-16 Amino purine derivatives Expired CA967564A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA210,441A CA973875A (en) 1969-11-17 1974-10-01 Purine derivatives and method of preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87744369A 1969-11-17 1969-11-17

Publications (1)

Publication Number Publication Date
CA967564A true CA967564A (en) 1975-05-13

Family

ID=25369972

Family Applications (1)

Application Number Title Priority Date Filing Date
CA098,272A Expired CA967564A (en) 1969-11-17 1970-11-16 Amino purine derivatives

Country Status (26)

Country Link
US (1) US3666856A (es)
JP (1) JPS5429520B1 (es)
AT (1) AT309696B (es)
BE (1) BE759011A (es)
BR (1) BR6915136D0 (es)
CA (1) CA967564A (es)
CH (2) CH555833A (es)
CS (1) CS181701B2 (es)
DE (1) DE2056327C2 (es)
DK (1) DK128117B (es)
ES (2) ES385590A1 (es)
FI (1) FI54315C (es)
FR (1) FR2073364B1 (es)
GB (2) GB1338905A (es)
HU (1) HU163812B (es)
IE (1) IE34737B1 (es)
IL (1) IL35658A (es)
LU (1) LU62071A1 (es)
MC (1) MC869A1 (es)
NL (1) NL171589C (es)
NO (1) NO128156B (es)
PL (1) PL81167B1 (es)
SE (1) SE385374B (es)
YU (2) YU35033B (es)
ZA (1) ZA707722B (es)
ZM (1) ZM12970A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4081534A (en) * 1973-09-11 1978-03-28 Burroughs Wellcome Co. Amino purine nucleosides as autoimmune suppressant agents
GB1562899A (en) * 1975-06-17 1980-03-19 Wellcome Found Pharmaceutical compositions containing substituted 9-( -d-arabnofuranosyl)purine-5'-phosphate and salts thereof
US4210745A (en) * 1978-01-04 1980-07-01 The United States Of America As Represented By The Department Of Health, Education And Welfare Procedure for the preparation of 9-β-D-arabinofuranosyl-2-fluoroadenine
DE3319282A1 (de) * 1983-05-27 1984-11-29 Gödecke AG, 1000 Berlin Verwendung von adenosin bei der behandlung von herpes
GB8712745D0 (en) * 1987-05-30 1987-07-01 Wellcome Found Antiviral compounds
KR0138996B1 (ko) * 1988-03-16 1998-04-30 레이몬드 에이치. 칸 치환된 아데닌 유도체 및 이를 함유하는 약제학적 조성물
IE882585L (en) * 1988-08-25 1990-02-25 Prendergast Patrick T Viral treatment system
US5292725A (en) * 1988-08-25 1994-03-08 Prendergast Patrick T Administering particular compounds against various parasites, mycoplasmas, other indications and other infections
US5681941A (en) * 1990-01-11 1997-10-28 Isis Pharmaceuticals, Inc. Substituted purines and oligonucleotide cross-linking
US5308837A (en) * 1990-08-22 1994-05-03 Merrell Dow Pharmaceuticals Inc. 5'-amine substituted adenosine analogs as immunosuppressants
US6338963B1 (en) 1994-07-25 2002-01-15 Neotherapeutics, Inc. Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis
US6232463B1 (en) 1997-10-09 2001-05-15 Isis Pharmaceuticals, Inc. Substituted purines and oligonucleotide cross-linking
US6303617B1 (en) 1998-05-04 2001-10-16 Neotherapeutics, Inc. Serotonin-like 9-substituted hypoxanthine and methods of use
US6288069B1 (en) 1999-11-16 2001-09-11 Neotherapeutics, Inc. Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue
US6407237B1 (en) 2001-02-21 2002-06-18 Neotherapeutics, Inc. Crystal forms of 9-substituted hypoxanthine derivatives
US6849735B1 (en) * 2000-06-23 2005-02-01 Merck Eprova Ag Methods of synthesis for 9-substituted hypoxanthine derivatives
ES2385931T3 (es) 2000-07-07 2012-08-03 Spectrum Pharmaceuticals, Inc. MÉTODOS PARA EL TRATAMIENTO DE NEUROPATíA PERIFÉRICA INDUCIDA POR UNA ENFERMEDAD Y AFECCIONES RELACIONADAS.
US6759427B2 (en) 2001-04-20 2004-07-06 Spectrum Pharmaceuticals, Inc. Synthesis and methods of use of tetrahydroindolone analogues and derivatives
US20030055249A1 (en) * 2001-07-17 2003-03-20 Fick David B. Synthesis and methods of use of pyrimidine analogues and derivatives
CN105237602B (zh) * 2015-06-25 2018-05-18 新乡学院 一种2-氨基阿糖腺苷的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3208997A (en) * 1962-11-15 1965-09-28 Sankyo Co Process for preparing purine and pyrimidine nucleosides
US3407191A (en) * 1966-08-29 1968-10-22 Lilly Co Eli Adamantoate esters of nucleosides
JPH1097965A (ja) * 1996-09-20 1998-04-14 Sony Corp 生産管理方法

Also Published As

Publication number Publication date
IE34737B1 (en) 1975-08-06
YU280670A (en) 1979-12-31
FI54315B (fi) 1978-07-31
YU35033B (en) 1980-06-30
NO128156B (es) 1973-10-08
NL7016766A (es) 1971-05-19
IL35658A0 (en) 1971-01-28
JPS5429520B1 (es) 1979-09-25
US3666856A (en) 1972-05-30
ZA707722B (en) 1972-06-28
YU35034B (en) 1980-06-30
ZM12970A1 (en) 1972-07-21
IL35658A (en) 1974-10-22
LU62071A1 (es) 1971-08-12
BE759011A (fr) 1971-05-17
CS181701B2 (en) 1978-03-31
NL171589B (nl) 1982-11-16
BR6915136D0 (pt) 1973-04-19
GB1338906A (en) 1973-11-28
SE385374B (sv) 1976-06-28
FR2073364B1 (es) 1974-03-22
HU163812B (es) 1973-10-27
FI54315C (fi) 1978-11-10
IE34737L (en) 1971-05-17
FR2073364A1 (es) 1971-10-01
ES413787A1 (es) 1976-01-16
GB1338905A (en) 1973-11-28
NL171589C (nl) 1983-04-18
DE2056327C2 (de) 1984-10-11
DE2056327A1 (de) 1971-06-03
MC869A1 (fr) 1971-09-28
AT309696B (de) 1973-08-27
DK128117B (da) 1974-03-04
CH555833A (de) 1974-11-15
ES385590A1 (es) 1973-10-01
PL81167B1 (es) 1975-08-30
YU201978A (en) 1979-12-31
CH555344A (de) 1974-10-31

Similar Documents

Publication Publication Date Title
CA967564A (en) Amino purine derivatives
CA972373A (en) Amino acid derivatives
AU2279270A (en) Tricarboxystarch derivatives
AU1654170A (en) Benzoisothiazol derivatives
AU455821B2 (en) Amino purine derivatives
IE34738B1 (en) Amino purine derivatives
AU2230370A (en) Amino purine derivatives
AU455503B2 (en) Peptide derivatives
CA812849A (en) Peptide derivatives
CA823216A (en) Theophylline derivative
CA804593A (en) A-nor-steroid derivatives
AU454738B2 (en) Idenopyridine derivatives
CA806681A (en) 3-tropanyl-2-phenylacrylate derivatives
CA812239A (en) 7-amino-carbostyrile derivatives
AU454318B2 (en) Benzodiazephine derivatives
CA804028A (en) Furochromone derivatives
AU458600B2 (en) Methylenedioxy-quinazolinone derivatives
AU456958B2 (en) Bbs-benzimidazole derivatives
AU456690B2 (en) Pleuromutalin derivatives
AU455293B2 (en) Propargyle derivatives
AU447115B2 (en) Pyrimidinylpurazole derivatives
CA811728A (en) Hexahalocyclopentadiene derivatives
AU454556B2 (en) d-CARBOLINE DERIVATIVES
AU426674B2 (en) Nitrofurane derivatives
AU436551B2 (en) Pyrimidopyridazine derivatives